康芝药业：关于公司控股股东部分股份质押展期的公告

Group 1 - The core point of the article is that Kangzhi Pharmaceutical announced the pledge extension of shares held by its controlling shareholder, Hainan Hongshi Investment Co., Ltd. [1] - The total number of shares pledged in this extension amounts to 84,900,000 shares [1]